Displaying drugs 376 - 400 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Anthrax immune globulin human | Not Available |  | An immunizing agent used for the treatment of inhalational anthrax in adult and pediatric patients in combination with antibacterial agents. | Amino Acids, Peptides, and Proteins / Blood Proteins / Human Immunoglobulin / Immunoglobulins / Proteins / Serum / Serum Globulins / Vaccines |
| Anistreplase | 59042.3 C2569H3928N746O781S40 |  | A form of recombinant human tissue plasminogen activator used in the emergency treatment of myocardial infarction and pulmonary emboli. | Enzymes |
| Anifrolumab | 148000.0 | | A monoclonal antibody that inhibits type 1 interferon receptors, indicated in the treatment of moderate to severe systemic lupus erythematosus. | Selective Immunosuppressants |
| Angiotensin II | Not Available | | A peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock. | Angiotensin II, antagonists & inhibitors / Angiotensins / Autacoids / Neuropeptides / Oligopeptides / Peptide Hormones / Vasoconstrictor Agents |
| Andexanet alfa | Not Available | | A recombinant Factor Xa used to reverse anticoagulation caused by rivaroxaban and apixaban. | Antidotes |
| Ancestim | 18540.0 C1662H2650N422O512S18 |  | A human stem cell factor used in combination with filgrastim during autologous peripheral blood progenitor cell (PBPC) transplantation to increase PBPC mobilization for improved collection. | Colony-Stimulating Factors |
| Anakinra | 17257.6 C759H1186N208O232S10 |  | A recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA). | Interleukin Inhibitors |
| Anacaulase | 23000.0 | | A mix of proteolytic enzymes indicated for eschar removal in adults with deep partial thickness and/or full-thickness thermal burns. | Administration, Topical / Cysteine Endopeptidases / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Enzymes / Enzymes and Coenzymes / Hydrolases / Peptide Hydrolases / Wound Healing |
| Amivantamab | 148000.0 | | An EGF and MET receptor targeted antibody indicated in the treatment of non-small cell lung cancer with an EGFR 20 exon insertion mutation. | Antineoplastic Agents, Immunological |
| Alteplase | 59000.0 C2569H3928N746O781S40 |  | A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli. | Enzymes |
| Alpha-1-proteinase inhibitor | 44324.5 C2001H3130N514O601S10 |  | A purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency. | Proteinase Inhibitors |
| Alirocumab | 146000.0 C6472H9996N1736O2032S42 |  | A PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-cholesterol (LDL-C). | Hypercholesterolemia, drug therapy / Hypolipidemic Agents Indicated for Hyperlipidemia / PCSK9 Inhibitor |
| Alglucosidase alfa | 105270.802 C4435H6739N1175O1279S32 |  | An acid alpha- glucosidase (GAA) derivative used as an enzyme replacement therapy for the treatment of Pompe disease in infants and pediatric patients caused by GAA deficiency. | Enzymes / Glucosidases / Glycogen Storage Disease Type II / Hydrolytic Lysosomal Glycogen-specific Enzyme |
| Alglucerase | 55597.4 C2532H3854N672O711S16 |  | A form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease. | Enzymes |
| Alemtuzumab | 145453.8 C6468H10066N1732O2005S40 |  | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. | Selective Immunosuppressants |
| Alefacept | 51801.1 C2306H3594N610O694S26 |  | A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. | Selective Immunosuppressants |
| Aldesleukin | 15314.8 C690H1115N177O202S6 |  | A recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma. | Interleukins |
| Albutrepenonacog alfa | 125000.0 C5077N7846O1588PS67 |  | A recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B. | Albumins / Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Drugs that are Mainly Renally Excreted / Enzyme Precursors / Enzymes and Coenzymes / Hemostatics / Protein Precursors / Proteins / Recombinant Proteins |
| Albumin iodinated I-131 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume and other diagnostic purposes. | Radiopharmaceutical Activity |
| Albumin iodinated I-125 serum | Not Annotated | | A radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume. | Radioactive Diagnostic Agent |
| Albumin human | 66472.2 C2936H4624N786O889S41 |  | A purified form of human serum albumin used to replace lost albumin in patients with hypoalbuminemia, to treat hypovolemia and ascites, and as a part of some diagnostic imaging kits. | Blood Substitutes and Plasma Protein Fractions |
| Albumin Aggregated | Not Annotated | | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for... | Radioactive Diagnostic Agent |
| Albiglutide | 72970.0 C3232H5032N864O979S41 |  | A GLP-1 agonist used to manage type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues / Incretin Mimetics |
| Agkistrodon piscivorus antivenin | Not Available | | A mixture of antibodies used to treat venomous snake bites from the Crotalinae family (pit vipers). | Antivenins |
| Agalsidase beta | 45351.6 C2029H3080N544O587S27 |  | A recombinant human alpha-galactosidase indicated to treat Fabry disease, a genetic deficiency in the enzyme leading to buildup of globotriaosylceramide. | Enzymes / Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme |
Displaying drugs 376 - 400 of 407 in total